TRIOGEN caps 250 mg bte 100 pce

7680674310013 CH-67431 A16AX12 07.99.0.

Reimbursement limitations:

TRIOGEN

TRIOGEN est remboursé pour le traitement de la maladie de Wilson (maladie de surcharge en …

TRIOGEN caps 250 mg bte 100 pce
TRIOGEN caps 250 mg bte 100 pce
TRIOGEN caps 250 mg bte 100 pce
1 / 3
google

Details

Product number
6743101
CPT
-
Packaging group
100
Unit
Kapsel(n)
Composition
trientini dihydrochloridum 250 mg, silica colloidalis anhydrica, acidum stearicum, Kapselhülle: gelatina, aqua purificata, natrii laurilsulfas corresp. natrium 0.0048 mg, E 172 (flavum), E 172 (rubrum), E 171, Drucktinte: lacca, alcohol butylicus, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula.

Articles (1)

Triogen 250 mg, Kapseln
Kapseln
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/07/2024
Patient information leaflet
Français
16/07/2024
Patient information leaflet
Italien
16/07/2024
Professional SmPC
Allemand
08/07/2024
Professional SmPC
Français
08/07/2024
Professional SmPC
Italien
08/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.0048 MG Substance HBESI
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 4494.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2020

Authorization holder

IDEOGEN AG

8807 Freienbach

Authorization information

Swissmedic authorization number
67431
Drug name
Triogen, Kapseln
Galenic form
KAPS
ATC Code
A16AX12
Authorization status
Z
Dispensation category
B
First authorization
28/05/2020
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Behandlung von Morbus Wilson bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen

Packaging details

Description (FR)
TRIOGEN caps 250 mg bte 100 pce
Description (DE)
TRIOGEN Kaps 250 mg Ds 100 Stk
Market launch
28/05/2020
Narcotic (BTM)
No

Other packaging sizes